Welly Travel Medicine Kit

Product NDC: 72663-205
Requested package NDC: 72663-205-48
11-digit product format: 726630205
Labeler code: 72663
Product ID: 72663-205_a359ac07-b81b-2440-e053-2a95a90a4b16
Type: HUMAN OTC DRUG
Nonproprietary name: MECLIZINE HYDROCHLORIDE, IBUPROFEN, LOPERAMIDE HYDROCHLORIDE, DOXYLAMINE SUCCINATE
Dosage form: KIT
Labeler: Welly Health PBC
Application: part336
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2020-04-06
Marketing end: 0000-00-00
Active strength: 0
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	72663-205	72663-205-48	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	`bd6a592717d7…`	`303034d00443…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
1e73f975-1ce7-705e-2bcf-788b1b5e24ba	Product name	5	20251124
59361619-24d9-b610-eca6-5a7f25ed5e03	Product name	5	20240909
10f838ef-a72b-645d-80f8-e2255205c3b1	Product name	6	20240805
16cde546-8deb-4df2-a072-dab5566ede95	Product name	1	20231003
f6d1b8d7-3bd1-4248-eddd-b60565c88015	Product name	4	20230808
874f4e63-49d2-5150-5d77-052172814ebd	Product name	6	20230105
ac6963c4-31c6-325f-ee58-83a0a06597ad	Product name	5	20221206
f4368033-af8c-41bf-a84b-ff77392b8522	Product name	1	20161229
557673c2-8256-b351-e863-4ec71a5a64b0	Product name	2	20160714
dbc9a339-6215-4e94-9546-57a3b34902ce	Product name	1	20160517
61c18d4e-b552-5478-8fc0-df38b93e3100	Product name	1	20140508
7b2938c9-7eb7-e312-ae90-f54f4240361e	Product name	1	20140508
997601aa-bb5f-6971-6b90-a21132c12c7b	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
72663-205-48	2022-01-28	C162847	48780-1	d6a99b39-a36e-a426-e053-dadaa90af4c2	Welly Travel Medicine Kit

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
72663-205-48	Welly Travel Medicine Kit	1 in 1 KIT	KIT	1		2
72663-369-48	Welly Travel Medicine Kit	8 in 1 BLISTER PACK	TABLET	8	25 mg	2
72663-428-48	Welly Travel Medicine Kit	16 in 1 BOTTLE	TABLET	16	200 mg	2
72663-567-48	Welly Travel Medicine Kit	12 in 1 BLISTER PACK	TABLET	12	2 mg	2
72663-632-48	Welly Travel Medicine Kit	8 in 1 BLISTER PACK	TABLET	8	25 mg	2
72663-746-48	Welly Travel Medicine Kit	2 in 1 KIT	TABLET, CHEWABLE		125 mg	2
72663-746-48	Welly Travel Medicine Kit	6 in 1 BLISTER PACK	TABLET, CHEWABLE	12	125 mg	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
72663-205	WELLY TRAVEL MEDICINE KIT (MECLIZINE HYDROCHLORIDE, IBUPROFEN, LOPERAMIDE HYDROCHLORIDE, DOXYLAMINE SUCCINATE) KIT [WELLY HEALTH PBC]	2	Legacy NDC, 7 package rows	20200424_61a66722-a626-4871-a13c-7c9f3d6d76df.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1101446	doxylamine succinate 25 MG Oral Tablet	PSN	61a66722-a626-4871-a13c-7c9f3d6d76df	2
310965	ibuprofen 200 MG Oral Tablet	PSN	61a66722-a626-4871-a13c-7c9f3d6d76df	2
978010	loperamide HCl 2 MG Oral Tablet	PSN	61a66722-a626-4871-a13c-7c9f3d6d76df	2
995666	meclizine HCl 25 MG Oral Tablet	PSN	61a66722-a626-4871-a13c-7c9f3d6d76df	2
314221	simethicone 125 MG Chewable Tablet	PSN	61a66722-a626-4871-a13c-7c9f3d6d76df	2
1101446	doxylamine succinate 25 MG Oral Tablet	SCD	61a66722-a626-4871-a13c-7c9f3d6d76df	2
310965	ibuprofen 200 MG Oral Tablet	SCD	61a66722-a626-4871-a13c-7c9f3d6d76df	2
978010	loperamide hydrochloride 2 MG Oral Tablet	SCD	61a66722-a626-4871-a13c-7c9f3d6d76df	2
995666	meclizine hydrochloride 25 MG Oral Tablet	SCD	61a66722-a626-4871-a13c-7c9f3d6d76df	2
314221	simethicone 125 MG Chewable Tablet	SCD	61a66722-a626-4871-a13c-7c9f3d6d76df	2
310965	ibuprofen 200 MG (as ibuprofen sodium 256 MG) Oral Tablet	SY	61a66722-a626-4871-a13c-7c9f3d6d76df	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
72663-205-48	72663020548	1 KIT in 1 KIT (72663-205-48) * 2 BLISTER PACK in 1 KIT (72663-746-48) > 6 TABLET, CHEWABLE in 1 BLISTER PACK * 12 TABLET in 1 BLISTER PACK (72663-567-48) * 8 TABLET in 1 BLISTER PACK (72663-369-48) * 16 TABLET in 1 BOTTLE (72663-428-48) * 8 TABLET in 1 BLISTER PACK (72663-632-48)	1 kit	2020-04-06	0000-00-00	No	No	Current